Pallas Health vs bmiMD: Clinician Choice and Pricing Compared
Pallas Health vs bmiMD: If you want a clinician to pick between brand-name pens and a compounded option, Pallas Health emphasizes a clinician-selected route and includes provider care in one all-in plan price; bmiMD emphasizes tiered prepaid billing options for compounded tirzepatide and lower long-term monthly equivalents. Early verdict: choose Pallas Health if you want one intake that covers both FDA-approved brands and compounded options with provider care included. Choose bmiMD if you prefer lower long-term monthly equivalents in exchange for a multi-month commitment.
Pallas Health vs bmiMD at a glance
Both providers offer compounded GLP-1/Tirzepatide options and note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Key differences appear in plan structure, pricing commitments and clinician access.
| Criteria | Pallas Health | bmiMD |
|---|---|---|
| Compounded starting price | Compounded semaglutide $139 first month; compounded tirzepatide $179 first month | Compounded tirzepatide $179 month-to-month; $159/mo 3-month; $149/mo 6-month; $139/mo 12-month |
| Billing model | All-in plan price; compounded plans renew every 12 weeks ($597 per 12 weeks semaglutide) | Four billing options with lower long-term monthly equivalent; lowest price requires 12-month commitment |
| Brand-name medications | Offers Wegovy, Ozempic, Zepbound and Mounjaro as clinician options; brand-name cash-pay prices listed | No brand-name GLP-1s captured; focused on compounded tirzepatide |
| Clinician access and care | US-licensed clinician reviews history and personalizes plan; provider care, check-ins and messaging included with no membership fee | Claims 24/7 clinician access and online refills and delivery |
| Shipping and fulfillment | Free expedited discreet shipping; compounded in the USA; medications prepared by US-licensed compounding pharmacies | Free subscription shipping on every order; prepared in state-licensed pharmacy |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
1. Pricing structure and commitments
The difference in how you pay is a primary distinction. Pallas Health lists compounded semaglutide at $139 first month, then $597 every 12 weeks which the company presents as a $199/month average; compounded tirzepatide is $179 first month, then $897 every 12 weeks (a $299/month average). Pallas also lists cash-pay brand-name prices for Wegovy, Zepbound, Ozempic and Mounjaro, and notes that compounded plans are priced by medication rather than by milligram so titration does not raise the plan price.
bmiMD offers four billing options for compounded tirzepatide with a clear tradeoff: month-to-month is $179/month, while prepaying reduces the monthly equivalent to $159 for three months, $149 for six months, and $139 for a 12-month plan. bmiMD explicitly states the lowest price requires a 12-month commitment and that total prepaid charge should be confirmed.
2. Clinician role and included care
Pallas emphasizes that a US-licensed clinician reviews health history and personalizes whether you receive an FDA-approved brand or a compounded preparation, and that provider care, ongoing check-ins and messaging are included with no membership fee. bmiMD highlights clinician review for eligibility and claims 24/7 clinician access as a feature. Both sources say treatment is available only when a licensed clinician determines it is medically appropriate.
Check Pallas clinician-led approach
3. Shipping, pharmacy and regulatory notes
Both providers advertise free shipping. Pallas specifies free expedited discreet shipping and that compounded medications are prepared by US-licensed compounding pharmacies and may differ in appearance from images shown. bmiMD states medication is prepared in a state-licensed pharmacy and delivered to your door. Both include the regulatory caution that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
4. Who each provider seems best for
Pallas Health is best for patients who want a clinician to choose between brand-name pens and a per-patient compounded preparation and prefer an all-in plan price that includes provider care and messaging with no membership fee. bmiMD is best for people who want lower long-term monthly equivalents and are willing to confirm eligibility, total prepaid cost and state availability before enrolling, including committing to a longer prepaid plan to reach the lowest monthly rate.
Choose based on the difference that matters to you
Decide primarily on payment flexibility versus clinician-selected access to brand and compounded options. Pallas bundles clinician care and offers both brand and compounded routes from one intake. bmiMD focuses on multi-month pricing tiers for compounded tirzepatide and emphasizes lower long-term monthly equivalents when you commit to longer plans.
Conclusion: Pallas Health vs bmiMD
In a direct comparison, Pallas Health emphasizes clinician choice between FDA-approved brand-name GLP-1s and compounded preparations, with provider care included in an all-in plan price; bmiMD emphasizes tiered billing options for compounded tirzepatide that lower the monthly equivalent when you commit to longer prepaid plans. Pallas Health vs bmiMD comes down to whether you prioritize clinician-selected brand-versus-compound options and included care, or lower long-term monthly equivalents tied to a multi-month commitment.
Choose Pallas Health if…
- You want a US-licensed clinician to review your history and choose between FDA-approved pens and a compounded option, with provider care, check-ins and messaging included and no membership fee.
- You prefer an all-in plan price and the option of brand-name Wegovy, Ozempic, Zepbound or Mounjaro alongside compounded semaglutide or tirzepatide.
Choose bmiMD if…
- You want compounded tirzepatide with four billing options and lower long-term monthly equivalents and are prepared to confirm prepaid totals and state availability before enrolling.